Papakostas, G. I.
Johe, K.
Hand, H.
Drouillard, A.
Russo, P.
Kay, G.
Kashambwa, R.
Hoeppner, B.
Flynn, M.
Yeung, A.
Martinson, M. A.
Fava, M.
Funding for this research was provided by:
Neuralstem, Inc.
Article History
Received: 20 March 2018
Revised: 5 November 2018
Accepted: 26 November 2018
First Online: 9 January 2019
Compliance with ethical standards
:
: Authors from MGH-CTNI Dr. Bettina Hoepnner, Dr. Albert Yeung, Martina Flynn, Rutendo Kashambwa, and Max Martinson do not have any conflicts of interest to disclose. Dr. Maurizio Fava: For a complete list of lifetime disclosures of Dr. Maurizio Fava, please see ExternalRef removed Dr. Papakostas has the following lifetime disclosures: Commercial Enterprises Relationship/Role Abbott Laboratories honoraria consultant Acadia Pharmaceuticals Inc consultant* Alkermes Inc honoraria consultant Asopharma America Central Y Caribe honoraria Astra Zeneca PLC honoraria consultant research support Avanir Pharmaceuticals honoraria consultant Axsome Therapeutics consultant* Brainsway Ltd. honoraria consultant Boston Pharmaceuticals, Inc. consultant* Bristol-Myers Squibb Company research support consultant honoraria speakers bureau Cephalon, Inc. consultant honoraria Dey Pharma L.P. consultant honoraria Eli Lilly and Company consultant honoraria Evotec AG consultant honoraria Forest Pharmaceuticals, Inc research support honoraria Genentech, Inc consultant* Genomind, Inc consultant* GlaxoSmithKline plc honoraria Consultant Grunbiotics Pty LTD honoraria Inflabloc Pharmaceuticals, Inc consultant honoraria Janssen Global Services LLC consultant* Jazz Pharmaceuticals, Inc. consultant Honoraria Johnson & Johnson Companies consultant* H. Lundbeck A/S honoraria consultant Medichem Pharmaceuticals, Inc honoraria Meiji Seika Pharma Co. Ltd honoraria Methylation Sciences Inc consultant* Mylan Inc consultant* National Institute of Mental Health research support Neuralstem, Inc research support* Novartis Pharma AG honoraria consultant One Carbon Therapeutics consultant* Osmotica Pharmaceutical Corp. consultant* Otsuka Pharmaceuticals honoraria consultant Pamlab, LLC honoraria consultant research support Pfizer, Inc. honoraria research support consultant speakers bureau Pharma Trade SAS honoraria Pierre Fabre Medicament consultant honoraria Ridge Diagnostics (formerly research support Precision Human Biolaboratories, Inc.) consultant honoraria Shire Pharmaceuticals Group plc honoraria consultant Sunovion Pharmaceuticals research support consultant honoraria Taisho Pharmaceutical Co, Ltd consultant* Takeda Pharmaceutical Company LTD consultant honoraria Tal Medical research support Theracos, Inc consultant honoraria research support Titan Pharmaceuticals Inc honoraria Wyeth Pharmaceuticals Inc consultant honoraria Dr. Papakostas has served as a consultant for Abbott Laboratories, Acadia Pharmaceuticals, Inc*, Alkermes, Inc, AstraZeneca PLC, Avanir Pharmaceuticals, Axsome Therapeutics*, Boston Pharmaceuticals, Inc., Brainsway Ltd, Bristol-Myers Squibb Company, Cephalon Inc., Dey Pharma, L.P., Eli Lilly Co., Genentech, Inc*, Genomind, Inc*, GlaxoSmithKline, Evotec AG, H. Lundbeck A/S, Inflabloc Pharmaceuticals, Janssen Global Services LLC*, Jazz Pharmaceuticals, Johnson & Johnson Companies*, Methylation Sciences Inc, Mylan Inc*, Novartis Pharma AG, One Carbon Therapeutics, Inc*, Osmotica Pharmaceutical Corp.*, Otsuka Pharmaceuticals, PAMLAB LLC, Pfizer Inc., Pierre Fabre Laboratories, Ridge Diagnostics (formerly known as Precision Human Biolaboratories), Shire Pharmaceuticals, Sunovion Pharmaceuticals, Taisho Pharmaceutical Co, Ltd, Takeda Pharmaceutical Company LTD, Theracos, Inc., and Wyeth, Inc. Dr. Papakostas has received honoraria (for lectures or consultancy) from Abbott Laboratories, Acadia Pharmaceuticals Inc, Alkermes Inc, Asopharma America Cntral Y Caribe, Astra Zeneca PLC, Avanir Pharmaceuticals, Bristol-Myers Squibb Company, Brainsway Ltd, Cephalon Inc., Dey Pharma, L.P., Eli Lilly Co., Evotec AG, Forest Pharmaceuticals, GlaxoSmithKline, Inflabloc Pharmaceuticals, Grunbiotics Pty LTD, Jazz Pharmaceuticals, H. Lundbeck A/S, Medichem Pharmaceuticals, Inc, Meiji Seika Pharma Co. Ltd, Novartis Pharma AG, Otsuka Pharmaceuticals, PAMLAB LLC, Pfizer, Pharma Trade SAS, Pierre Fabre Laboratories, Ridge Diagnostics, Shire Pharmaceuticals, Sunovion Pharmaceuticals, Takeda Pharmaceutical Company LTD, Theracos, Inc., Titan Pharmaceuticals, and Wyeth Inc. Dr. Papakostas has received research support (paid to hospital) from AstraZeneca PLC, Bristol-Myers Squibb Company, Forest Pharmaceuticals, the National Institute of Mental Health, Neuralstem, Inc*, PAMLAB LLC, Pfizer Inc., Ridge Diagnostics (formerly known as Precision Human Biolaboratories), Sunovion Pharmaceuticals, Tal Medical, and Theracos, Inc. Dr. Papakostas has served (not currently) on the speaker’s bureau for BristolMyersSquibb Co and Pfizer, Inc. * Asterisk denotes activity undertaken on behalf of Massachusetts General Hospital. All authors from Neuralstem were employees of Neuralstem with financial interest during the study. Dr. Gary Kay is an employee of Cognitive Research Corporation which served as the contract research organization for this study. Dr. Kay is also the author/publisher of the CogScreen test used in the study.